Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of DOAC restart after traumatic intracranial haemorrhage
ISRCTN63161604Phase 3Recruiting
- Sponsor
- The Walton Centre
- Start
- Mar 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of apixaban, dabigatran, edoxaban and rivaroxaban in acute intracranial hemorrhage (ICH) (2 arms), sponsored by The Walton Centre. Started Mar 2025; status: recruiting.
02
Drugs
apixabandabigatranedoxabanrivaroxaban
03
Conditions
acute intracranial hemorrhage (ICH)
Beyond the preview
Go deeper on ISRCTN63161604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63161604.